Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit. Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings. Learn what new research shows about the key elements that establish trust between patients and health care professionals. Learn how to find a mentor and be a successful mentee during your DNP or PhD program. The “United by Unique” campaign is calling for a "fundamental shift in cancer care and health systems worldwide." Learn about the role of psychological resilience in dyadic coping and adjustment for couples facing cervical cancer. Theresa Brown, RN, reflects on the challenges of recent years and her hopes for nurses in 2025. Researchers presented data from the program during the American Society of Clinical Oncology GI Cancer Symposium. A new study identified patterns in palliative care use and showed which patients are least likely to receive it. The Nursing Equity Assessment Tool can help nurses systematically and efficiently screen patients for complex care needs. The program provided a creative outlet for oncology nurses to reflect on and share their stories. Learn how these teleconsultations supported patients and helped increase clinic capacity. Pierluigi Porcu, MD, discusses the phase II Tellomak trial and how nurses can help patients manage this rare disease. Samantha Shenoy, NP, shares why it's important for nurses and APPs to consider attending the annual meeting. Richard Newcomb, MD, shares insights from his ASH 2024 presentation and explains why nurses play a major role in outcomes. A group of nurses led development of a symptom management mobile app for patients recovering from breast surgery. Learn how a research team created a nurse-led insomnia intervention for survivors of cancer. Oncology nurses play a vital role in identifying the signs of treatment-related angiosarcoma during survivorship care. Dr. Bose joined Cancer Nursing Today at ASH 2024 to share insights on using anemia-supporting medications with ruxolitinib. Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, explains key takeaways from her myeloma research at ASH 2024.